Latest news with #WCG
Business Wire
30-06-2025
- Business
- Business Wire
industryGENOME Unveils Groundbreaking Clinical Trial PAO Market Map Report, Powered by AI-Assisted Market Intelligence
TAMPA, Fla.--(BUSINESS WIRE)--industryGENOME, a cutting-edge analytics firm specializing in granular precision insights, has released its first-ever Clinical Trial Patient Access Organization (PAO) Market Map Report, developed in collaboration with WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, and Crosstree. This report offers an unparalleled bottom-up analysis of the PAO sector, using AI-powered classification models to predict private company revenue and stratify market estimates across geographies, subsidiaries, and specialized capabilities. Transforming Industry Analysis with AI-Assisted Precision Leveraging its proprietary Industry Capabilities Classification System (ICCS ®), industryGENOME provides a standardized and globally applicable framework for categorizing businesses. The ICCS ® methodology enhances financial analysis, investment decision-making, and strategy development across the life sciences and healthcare industries. The report was developed in close collaboration with WCG, which played a pivotal role in identifying global industry participants to ensure the most comprehensive market representation. Crosstree assisted industryGENOME in industry classification quality assurance and predictive modeling, enhancing the precision of market insights. 'This report is the most sophisticated analysis of the clinical trial PAO sector to date, ' said Shane Senior, Managing Director at Crosstree. 'industryGENOME's AI-driven predictive engines achieve 85% classification accuracy, surpassing human classifiers, and ensuring the most precise industry intelligence for investors and market participants. The ability to scale this precision across large data sets is unprecedented.' Key Findings from the Clinical Trial PAO Market Map Report Total Market Revenue: $14.95 billion Industry Participants: Over 3,000 global Patient Access Organizations with detailed company profiles for each Industry Stratification: Freestanding, Mobile, Virtual, Provider Embedded, and Service Embedded Sites Top Industry Players: Velocity, IQVIA, PPD, AES, CenExel Clinical Research, ERG, Javara Advanced Market Mapping: AI-assisted data collection and synthesis for high-fidelity revenue estimates allowing for 'sum-of-the-parts' bottom-up market sizing Geo-Stratification Analysis: The United States leads with $10.6 billion in revenue, followed by the UK, Germany, and Australia Why This Report Sets a New Standard industryGENOME's bottom-up methodology, empowered by machine learning and predictive analytics, provides unprecedented insights into the PAO sector. The firm's mapped markets process, which identifies, collects, and analyzes micro-industry data, ensures highly precise revenue estimates, critical for investors, procurement specialists, and drug developers seeking strategic market positioning. Access the Report Today To access the Clinical Trial PAO Market Map Report, visit or contact Jordan Schiding at About industryGENOME industryGENOME is a market intelligence platform for the Health Sciences industry that continuously collects and analyzes millions of data points on pharma services companies, investors, deals, valuations, research, conferences, and news. It produces bottom-up market research reports and company profiles by combining AI with the expertise of industry investment professionals. The platform is distinguished by a proprietary, highly granular taxonomy that categorizes industry participant capabilities through defined relationships. This classification system delivers clean, precise, and actionable insights on the Health Sciences market. Using AI technologies—including natural language processing, machine translation, and supervised machine learning—industryGENOME classifies and curates data. In partnership with Crosstree, the platform trains its classification algorithm for accuracy and precision. Together, they are mapping the Health Sciences market one company at a time to deliver detailed, bottom-up industry segment insights. Learn more at About Crosstree Crosstree is a distinguished boutique investment banking firm focused exclusively on the needs of middle-market companies within three subsectors of the life sciences and healthcare industries: pharmaceutical services, diagnostics and tools, and digital health. Since 2004, Crosstree has advised on more completed transactions in these collective subsectors than any other investment bank. The firm provides clients a full suite of advisory and capital raising services, including both buy-and sell-side mergers and acquisitions advisory, private capital raising, strategic advisory, and valuations. Crosstree's narrow industry focus provides clients the expertise common of a bulge-bracket investment banking firm to middle-market companies and investors, with unparalleled industry insights, well-established strategic relationships across the globe and superior access to capital markets. From our offices in Tampa, Florida, Crosstree has advised clients throughout North America, Europe, India, China, Latin America, and Australia on transactions ranging from $25 million to more than $1 billion. About WCG WCG is at the forefront of accelerating clinical research worldwide, serving as the trusted and preferred partner to biopharmaceutical and medical device companies, contract research organizations (CROs), research institutions, and site partners. Offering a unique combination of expertise, next-generation data and insights, and tech-enabled solutions, WCG reduces complexity and optimizes study operations and outcomes while maintaining the highest standards of human participant protection. For more than 55 years, WCG has maintained a relentless commitment to efficiency, safety, and impact, empowering clinical trials to deliver life-improving therapies swiftly. For more information, please visit or follow us on LinkedIn or X @WCGClinical.
Yahoo
30-06-2025
- Business
- Yahoo
industryGENOME Unveils Groundbreaking Clinical Trial PAO Market Map Report, Powered by AI-Assisted Market Intelligence
TAMPA, Fla., June 30, 2025--(BUSINESS WIRE)--industryGENOME, a cutting-edge analytics firm specializing in granular precision insights, has released its first-ever Clinical Trial Patient Access Organization (PAO) Market Map Report, developed in collaboration with WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, and Crosstree. This report offers an unparalleled bottom-up analysis of the PAO sector, using AI-powered classification models to predict private company revenue and stratify market estimates across geographies, subsidiaries, and specialized capabilities. Transforming Industry Analysis with AI-Assisted Precision Leveraging its proprietary Industry Capabilities Classification System (ICCS®), industryGENOME provides a standardized and globally applicable framework for categorizing businesses. The ICCS® methodology enhances financial analysis, investment decision-making, and strategy development across the life sciences and healthcare industries. The report was developed in close collaboration with WCG, which played a pivotal role in identifying global industry participants to ensure the most comprehensive market representation. Crosstree assisted industryGENOME in industry classification quality assurance and predictive modeling, enhancing the precision of market insights. "This report is the most sophisticated analysis of the clinical trial PAO sector to date," said Shane Senior, Managing Director at Crosstree. "industryGENOME's AI-driven predictive engines achieve 85% classification accuracy, surpassing human classifiers, and ensuring the most precise industry intelligence for investors and market participants. The ability to scale this precision across large data sets is unprecedented." Key Findings from the Clinical Trial PAO Market Map Report Total Market Revenue: $14.95 billion Industry Participants: Over 3,000 global Patient Access Organizations with detailed company profiles for each Industry Stratification: Freestanding, Mobile, Virtual, Provider Embedded, and Service Embedded Sites Top Industry Players: Velocity, IQVIA, PPD, AES, CenExel Clinical Research, ERG, Javara Advanced Market Mapping: AI-assisted data collection and synthesis for high-fidelity revenue estimates allowing for "sum-of-the-parts" bottom-up market sizing Geo-Stratification Analysis: The United States leads with $10.6 billion in revenue, followed by the UK, Germany, and Australia Why This Report Sets a New Standard industryGENOME's bottom-up methodology, empowered by machine learning and predictive analytics, provides unprecedented insights into the PAO sector. The firm's mapped markets process, which identifies, collects, and analyzes micro-industry data, ensures highly precise revenue estimates, critical for investors, procurement specialists, and drug developers seeking strategic market positioning. Access the Report Today To access the Clinical Trial PAO Market Map Report, visit or contact Jordan Schiding at About industryGENOME industryGENOME is a market intelligence platform for the Health Sciences industry that continuously collects and analyzes millions of data points on pharma services companies, investors, deals, valuations, research, conferences, and news. It produces bottom-up market research reports and company profiles by combining AI with the expertise of industry investment professionals. The platform is distinguished by a proprietary, highly granular taxonomy that categorizes industry participant capabilities through defined relationships. This classification system delivers clean, precise, and actionable insights on the Health Sciences market. Using AI technologies—including natural language processing, machine translation, and supervised machine learning—industryGENOME classifies and curates data. In partnership with Crosstree, the platform trains its classification algorithm for accuracy and precision. Together, they are mapping the Health Sciences market one company at a time to deliver detailed, bottom-up industry segment insights. Learn more at About Crosstree Crosstree is a distinguished boutique investment banking firm focused exclusively on the needs of middle-market companies within three subsectors of the life sciences and healthcare industries: pharmaceutical services, diagnostics and tools, and digital health. Since 2004, Crosstree has advised on more completed transactions in these collective subsectors than any other investment bank. The firm provides clients a full suite of advisory and capital raising services, including both buy-and sell-side mergers and acquisitions advisory, private capital raising, strategic advisory, and valuations. Crosstree's narrow industry focus provides clients the expertise common of a bulge-bracket investment banking firm to middle-market companies and investors, with unparalleled industry insights, well-established strategic relationships across the globe and superior access to capital markets. From our offices in Tampa, Florida, Crosstree has advised clients throughout North America, Europe, India, China, Latin America, and Australia on transactions ranging from $25 million to more than $1 billion. About WCG WCG is at the forefront of accelerating clinical research worldwide, serving as the trusted and preferred partner to biopharmaceutical and medical device companies, contract research organizations (CROs), research institutions, and site partners. Offering a unique combination of expertise, next-generation data and insights, and tech-enabled solutions, WCG reduces complexity and optimizes study operations and outcomes while maintaining the highest standards of human participant protection. For more than 55 years, WCG has maintained a relentless commitment to efficiency, safety, and impact, empowering clinical trials to deliver life-improving therapies swiftly. For more information, please visit or follow us on LinkedIn or X @WCGClinical. View source version on Contacts industryGENOME and Crosstree Media Contact: Hillary McCutcheonFreshwater Marketing813.992.1470hillary@ WCG Media Contact: Carmin Gade, PhDChief Marketing Officer, WCG484.351.9959cgade@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
IOL News
19-06-2025
- Business
- IOL News
Free transport initiative opens doors for Western Cape job seekers
Job seekers are encouraged to apply for this initiative. Image: WCG A second phase of the Jobseeker Travel Voucher Programme has been launched, enabling more job seekers to access free travel to prospective job opportunities. The Western Cape Government launched the initiative and said Phase 2 of the 'Getting You to Work' Jobseeker Travel Voucher Programme is aimed at tackling one of the greatest barriers facing unemployed residents - the cost of transport. The second phase was launched at the Town Centre Library in Mitchells Plain earlier this month. At the time, over 300 job seekers attended, registered, and received their gold cards (from Golden Arrow), which would allow them to travel free to access job opportunities across the Cape Metro. This programme was first introduced in February 2024, and since then, over 3,700 unemployed residents have registered through more than 150 employer partners. The goal of this programme is to remove the barrier created by the cost of public transport for residents to get to jobs. Phase 1 revealed particularly high uptake in communities such as Mitchells Plain, Khayelitsha, Delft, Gugulethu, and Philippi. Head of Communications for the Western Cape Mobility Department, Muneera Allie said too may capable and willing residents remain unemployed not because they lack skills or motivation, but simply because they cannot afford to get to an interview, training centre or their first day of work. 'Transport becomes an obstacle to residents achieving their full potential. This programme is about opening doors and restoring dignity. It is about recognising that every person deserves a fair shot at opportunity. Phase 2 aims to expand our reach, making it easier for more job seekers to register, access support, and get to where they need to be," Allie said. What's new in Phase 2: Self-registration: Job seekers can now register online directly, removing the previous requirement to go through a registered employer. Six free trips per voucher: Vouchers now carry six free trips, usable between 9am and 3pm, Monday to Friday. Extended duration: The programme has been extended until March 31, 2026. In Phase 2, employers in Cape Town are also encouraged to register as partners and offer the travel vouchers to prospective employees. This initiative forms part of the provincial government's Growth for Jobs Strategy, which aims to build an inclusive, resilient, and sustainable economy. Mobility MEC, Isaac Sileku, said that by assisting job seekers with free transport, the programme not only helps individuals and families but also strengthens the provincial economy by connecting people to opportunities. 'We know from our data that those who received vouchers had a greater chance of attending interviews, securing work, and participating in skills development. That is the pathway from unemployment to opportunity. That is the Growth for Jobs agenda in action. No one should be left behind because they cannot afford to get to an interview. We will continue to innovate, to listen, and to work together to create a mobility system that serves all the people of the Western Cape,' he said. How to apply: Job seekers can register online by completing the job seeker registration prompts on the portal and then presenting their ID at Golden Arrow kiosks to collect their gold card. [email protected] IOL
Time of India
17-06-2025
- Business
- Time of India
Gold set to gain share in forex reserves as dollar outlook dims: WGC
Gold reserves: A World Gold Council survey shows nearly half of central banks plan to boost gold reserves amid geopolitical risks. Gold may outpace the US dollar, with growing preference for safer, non-dollar assets including yuan and euro. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Gold could eat into the share of the US dollar in central bank forex holdings worldwide over the next five years, an annual World Gold Council (WGC) survey showed, underscoring a broad-based tilt toward safe-haven assets in a trading environment rocked by geopolitics and unpredictable trade tariffs. The yuan and the euro, too, might see share gains that reflect the shifting trade currents.'Nearly half of the central bank respondents intend to increase their own gold holdings in the coming year,' said Shaokai Fan, Global Head of Central Banks & Head of Asia-Pacific (ex-China). 'This is remarkable, especially considering how many record-high prices we've hit so far in 2025.'Gold prices have continued to surge through this year, in part aided by institutional purchases, after a record 2024 surge.'Notably, this reflects the current global financial and geopolitical environments,' Shaokai Fan said. 'Gold remains a strategic asset as the world faces uncertainty and tumult. Central banks are concerned about interest rates, inflation, and instability – all reasons to turn to gold to mitigate risk.'Central banks have bulked up gold holdings in recent years amid geopolitical and economic uncertainty. WCG said that central banks accumulated over 1,000 tonne of gold in each of the last three years, up significantly from the average 400-500 tonne over the preceding to the survey, which collected data from 73 of the world's central banks, were less sanguine about the prospects of the US dollar, which still is the world's reserve currency and the monetary unit in which goods are priced survey also revealed that 95% of respondents believe that global central bank gold reserves will increase over the next 12 months. This is a record high since it was first tracked in the 2019 survey and represents a 17% increase from the 2024 findings, WGC the American currency dollar maintains its position as the dominant global reserve currency, data from the International Monetary Fund's Currency Composition of Official Foreign Exchange Reserves (COFER) shows that the dollar's share has been on a gradual decline.'The majority of respondents (73%) see moderate or significantly lower US dollar holdings within global reserves over the next five years. Respondents also believe that the share of other currencies, such as the euro and renminbi, as well as gold, will increase over the same period,' the WCG survey said. Bank of Baroda May report, based on the WGC data, had shown that the gold holding by central banks climbed 4.1% annually between 2009 and top 10 holders are the US, Germany, Italy, France, Switzerland, Japan, Netherlands, China, Russia, and India.
BBC News
13-06-2025
- General
- BBC News
Isolation fear as fees 'price out' elderly Warwickshire students
A group of elderly students say they face becoming socially isolated after the cost of their college course more than doubled, leaving them "priced out", with friendships "torn apart".The students of upholstery, who are mostly aged between 70 and 80, attend weekly classes run by the Warwickshire College Group (WCG) at Leamington Spa course previously cost about £250 per term, however from September the fees will jump to £561. A spokesperson for WCG said the previous fee at £7.57 an hour did not "adequately cover the costs of delivering the course" and the increase was essential in order to keep the course "financially viable". The group added that without the increase, the course would need to be Jennifer Handscombe, 79, who has attended classes for more than seven years, described attendees as a "community". "There a lot of people who are dreadfully upset, there has been tears and people are genuinely worried," she said."It is something that has been part of their lives for so long, it is something that they do every week with a group of people that they know and love." Underlining her point the college had been an important source of interaction for people, she added: "We've learnt valuable skills, had our brains stimulated and our bodies kept active - but now we are being priced out of this activity."She said that relationships formed between staff and students would be "torn apart". A WCG spokesperson said leisure courses, which made up about 2% of the college's curriculum income, were "fully self-funded by participants" and were not supported by the Government or loans. They added that a minimum price of £17 had been set per teaching hour for the courses, which ensured other areas of the college did not need to subsidise the fees. Ms Handscombe acknowledged that cheaper classes were offered by the local authority, but said it was the quality of the college's teaching that drew the students."You're working with a group of people who you have developed a connection with and the tutors who run the courses are brilliant and do an amazing job," she said. Follow BBC Coventry & Warwickshire on BBC Sounds, Facebook, X and Instagram.
